Life Technologies Prices Offering of Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that it has priced an offering of senior notes.

The offering of $400 million aggregate principal amount of 3.5 percent senior notes due 2016 have an issue price of 99.84 percent of their face value. $400 million aggregate principal amount of 5 percent senior notes due 2021 have an issue price of 99.556 percent of their face value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.